clofibrate has been researched along with norethindrone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Lees, AM; Lees, RS | 1 |
| Bogentoft, C; Diding, E; Karlén, B; Ostelius, J; Sandström, H | 1 |
| Kwiterovich, PO; Margolis, S | 1 |
| Bagdade, JD | 1 |
| Parker, F; Short, JM | 1 |
4 review(s) available for clofibrate and norethindrone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Type IV hyperlipoproteinaemia.
Topics: Child; Cholesterol; Chylomicrons; Clofibrate; Diagnosis, Differential; Diet Therapy; Dietary Carbohydrates; Humans; Hyperlipidemias; Insulin; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Norethindrone; Pancreatitis; Phenotype; Triglycerides; Uric Acid; Vascular Diseases; Xanthomatosis | 1973 |
Therapy of the hyperlipoproteinemias.
Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Norethindrone; Phenformin; Triglycerides | 1972 |
Xanthomatosis associated with hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Norethindrone; Propionates; Thyroxine; Triglycerides; Xanthomatosis | 1970 |
7 other study(ies) available for clofibrate and norethindrone
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Therapy of the hyperlipidemias.
Topics: Anticoagulants; Blood Platelets; Child; Cholesterol; Chylomicrons; Clofibrate; Diet, Reducing; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Male; Nicotinic Acids; Norethindrone; Oxandrolone; Phenotype; Triglycerides | 1976 |
Studies on the application of integrated gas chromatography-mass spectrometry in drug purity control. Impurities in clofibrate, norethindrone, methandienone, haloperidol and meladrazine.
Topics: Butyrophenones; Chromatography, Gas; Clofibrate; Drug Contamination; Haloperidol; Mass Spectrometry; Methandrostenolone; Norethindrone; Temperature; Triazines | 1976 |